FLAGSHIP HARBOR ADVISORS, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
FLAGSHIP HARBOR ADVISORS, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$375,662
-3.9%
3,688
-4.8%
0.03%
-3.1%
Q2 2023$391,030
+47.3%
3,875
+34.3%
0.03%
+28.0%
Q1 2023$265,510
+1.8%
2,886
+0.4%
0.02%
-7.4%
Q4 2022$260,714
+18.0%
2,874
-1.2%
0.03%
+3.8%
Q3 2022$221,000
-9.1%
2,909
+1.2%
0.03%
-3.7%
Q2 2022$243,000
-4.0%
2,874
-0.5%
0.03%
+12.5%
Q1 2022$253,000
+3.3%
2,888
+3.1%
0.02%
+4.3%
Q4 2021$245,000
-51.7%
2,800
-49.6%
0.02%
-57.4%
Q3 2021$507,0000.0%5,5580.0%0.05%0.0%
Q2 2021$507,000
+10.0%
5,558
+3.1%
0.05%
+3.8%
Q1 2021$461,000
-12.2%
5,389
-3.0%
0.05%
-20.0%
Q4 2020$525,000
+15.9%
5,558
+6.5%
0.06%
+6.6%
Q3 2020$453,000
+51.0%
5,219
+51.8%
0.06%
+38.6%
Q2 2020$300,000
+26.1%
3,437
+19.2%
0.04%
-8.3%
Q1 2020$238,000
+17.2%
2,884
+34.7%
0.05%
+33.3%
Q4 2019$203,000
-0.5%
2,141
-9.0%
0.04%
-10.0%
Q3 2019$204,000
-1.4%
2,354
+3.4%
0.04%
-7.0%
Q2 2019$207,000
-6.8%
2,277
-1.7%
0.04%
-6.5%
Q1 2019$222,000
+15.6%
2,317
+3.1%
0.05%
-2.1%
Q4 2018$192,000
-17.6%
2,248
-16.7%
0.05%
+9.3%
Q3 2018$233,000
+17.1%
2,699
+2.2%
0.04%
+7.5%
Q2 2018$199,000
-0.5%
2,640
+14.0%
0.04%
-38.5%
Q3 2017$200,0002,3160.06%
Other shareholders
NOVARTIS A G shareholders Q3 2021
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders